The core pathological feature of psoriasis and cancer is excessive cell proliferation driven by the abnormal immune microenvironment, metabolic reprogramming, epigenetic reprogramming, and other abnormalities (KRT17 overexpression, lncRNAs, and ROS). This evidence concerns the gene KRT17 and cancer.